SFRP1 and ductal breast carcinoma in situ: Similarly, gene expression profiling of micro-dissected breast cancer samples from patients with matched IDC, DCIS and associated stroma found that Sfrp1 mRNA was reduced in the neoplastic epithelium during the progression from DCIS to IDC [36].